Alembic Pharmaceuticals is presently buying and selling at Rs. 617.60, up through 1.Ninety five factors or zero.32% from its preceding last of Rs. 615.65 on the BSE.
The scrip opened at Rs. 615.50 and has touched a high and occasional of Rs. 622.00 and Rs. 615.00 respectively. So a ways 2446 shares have been traded at the counter.
The BSE organization ‘A’ stock of face value Rs. 2 has touched a fifty two week high of Rs. 664.00 on 27-Sep-2018 and a 52 week low of Rs. 412.Forty on 24-May-2018.
Last one week excessive and coffee of the scrip stood at Rs. 636.50 and Rs. 549.10 respectively. The current market cap of the company is Rs. 11620.12 crore.
The promoters holding in the corporation stood at seventy two.Ninety six%, whilst Institutions and Non-Institutions held 14.88% and 12.16% respectively.
Alembic Pharmaceuticals’ entirely owned subsidiary, Orit Laboratories LLC has received US Food & Drug Administration (USFDA) acclaim for Glycopyrrolate drugs USP, 1 mg and 2 mg.
Bazaarinformation team has many years of experience, covering the physical and future commodities markets with prominent commodity & equity trading advising which shines further with extensive network to get research from ground levels to generate proper reporting and movements. We are able to get evens out of odds in volatile markets and stockings. ...
